Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

China’s Longi says it will begin mass production of base-metal PV modules in the second quarter of 2026 as rising silver ...

Chief among the factors driving a sense of optimism among the biopharma leaders was the unfreezing of the biotech investing ...

New research shows calves fed waste milk develop different immune cell and cytokine profiles than those fed salable milk, ...

Yeast left over from brewing beer can be transformed into edible "scaffolds" for cultivated meat—sometimes known as lab-grown ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...

As with most industries treated favorably in the Inflation Reduction Act (IRA) of 2022, the domestic energy storage market ...

Don Cowan and Mahyar Mohammadnezhad of Kiwa PI Berlin explain the importance of upstream diligence in ensuring long-term PV ...

Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

T1 Energy Inc. announced it has finalized its first sale of Section 45X production tax credits to an investment-grade buyer on December 30, 2025. The transaction is valued at $160 million. The sale ...